Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis

NCT04750135 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER_GOV

Sponsor class

Conditions

Ulcerative Colitis
Inflammatory Bowel Diseases

Interventions

DRUG: metformin 500 mg TID Oral Tablet
DRUG: Placebo

Sponsor

National Hepatology & Tropical Medicine Research Institute